Published in Hepatitis Weekly, May 17th, 2004
HCV disease burden is expected to rise during the next 10 years because of a maturing HCV population that has been infected for more than 20 years, the amount of time it takes for morbidity from HCV to emerge.
The new Pharmacor study entitled "Hepatitis C Virus" also found experts disagree about which patients are best suited for treatment given that HCV does not place all infected persons at risk of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.